Table 3 Genotypic frequency distribution of MTHFR for statistically significant clinical variables in relation with gender
From: Analysis of the MTHFR C677T variant with migraine phenotypes
Clinical variables | Gender | MTHFR Genotype % | ||
|---|---|---|---|---|
| Â | Â | CC | CT | TT |
Nausea | M | 10(100%) | 15(60%) | 5(71%) |
| Â | F | 55(85%) | 64(94%) | 16(89%) |
Osmophobia | M | 1(13%) | 3(14%) | 0(0%) |
| Â | F | 15(26%) | 21(35%) | 2(13%) |
Unilateral head pain | M | 4(50%) | 15(65%) | 3(50%) |
| Â | F | 36(63%) | 48(81%) | 17(100%) |
Bilateral head pain | M | 5(62%) | 13(62%) | 4(67%) |
| Â | F | 26(46%) | 15(26%) | 3(19%) |
Natural Remedy | M | 0(0%) | 2(9%) | 0(0%) |
| Â | F | 8(15%) | 14(25%) | 3(19%) |